meta content='width=device-width, initial-scale=1.0' name='viewport'/>

Thursday, June 22, 2017


Bioterrorism is a global threat: Many terrorists want it because the American government has used, Zika virus, Aids, and Ebola on population

Bioterrorism is a global threat: Many terrorists want it because the American government has used, Zika virus, Aids, and Ebola on population

Governments that use bio-weapons on other people find safety measures to protect their citizens

Over the past two decades, Biosafety in Microbiological and Biomedical Laboratories (BMBL) has become the code of practice for biosafety—the discipline addressing the safe handling and containment of infectious microorganisms and hazardous biological materials.

The principles of biosafety introduced in 1984 in the first edition of BMBL1 and carried through in this fifth edition remain steadfast. These principles are containment and risk assessment. 

The fundamentals of containment include the microbiological practices, safety equipment, and facility safeguards that protect laboratory workers, the environment, and the public from exposure to infectious microorganisms that are handled and stored in the laboratory.

Risk assessment is the process that enables the appropriate selection of microbiological practices, safety equipment, and facility safeguards that can prevent laboratory-associated infections (LAI). 

The purpose of periodic updates of BMBL is to refine guidance based on new knowledge and experiences and to address contemporary issues that present new risks that confront laboratory workers and the public health.

How the Zika virus is stored and used as a bioweapon by the US government

Classification:   Flaviviridae, Flavivirus

Agent: Zika virus

Strain: MR 766 (Original)

Biosafety level:   2

Biosafety classification is based on U.S. Public Health Service Guideline, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format:    Frozen

Storage conditions:   -70°C or colder

In this way, the code of practice will continue to serve the microbiological and biomedical community as a relevant and valuable authoritative reference. We are living in an era of uncertainty and change. 

New infectious agents and diseases have emerged. Work with infectious agents in public and private research, public health, clinical and diagnostic laboratories, and in animal care facilities has expanded.

Recent world events have demonstrated new threats of bioterrorism. For these reasons, organizations and laboratory directors are compelled to evaluate and ensure the effectiveness of their biosafety programs, the proficiency of their workers, as well as the capability of equipment, facilities, and management practices to provide containment and security of microbiological agents.

Similarly, individual workers who handle pathogenic microorganisms must understand the containment conditions under which infectious agents can be safely manipulated and secured. 

Application of this knowledge and the use of appropriate techniques and equipment will enable the microbiological and biomedical community to prevent personal, laboratory and environmental exposure to potentially infectious agents or biohazards.

The Occurrence of Laboratory-Associated Infections Published reports of LAIs first appeared around the start of the twentieth century. By 1978, four studies by Pike and Sulkin collectively identified 4,079 LAIs resulting in 168 deaths occurring between 1930 and 1978.2-5. 

These studies found that the ten most common causative agents of overt infections among workers were Brucella spp., Coxiella burnetii, hepatitis B virus (HBV), Salmonella typhi, Francisella tularensis, Mycobacterium tuberculosis, Blastomyces dermatitidis, Venezuelan equine encephalitis virus, Chlamydia psittaci, and Coccidioides immitis. 

The authors acknowledged that the 4,079 cases did not represent all LAIs that occurred during this period since many laboratories chose not to 2 Biosafety in Microbiological and Biomedical Laboratories report overt cases or conduct surveillance programs to identify sub-clinical or asymptomatic infections.

In addition, reports of LAIs seldom provided data sufficient to determine incidence rates, complicating quantitative assessments of risk. Similarly, there were no distinguishable accidents or exposure events identified in more than 80% of the LAIs reported before 1978. 

Studies did show that in many cases the infected person worked with a microbiological agent or was in the vicinity of another person handling an agent.

Who Owns the Zika Virus?

First published in February 2016, this incisive article by Guillaume Kress is of extreme relevance in relation to unfolding events.

The World Health Organization (WHO) declared the Zika virus a global health emergency on February 1st, 2016 without providing much detail on the disease. So here are some facts until we receive more information:

This sexually-transmitted virus has been around for 69 years and is marketed by two companies: LGC Standards (headquartered in the UK) and ATCC (headquartered in the US).

The LGC Group is:

“…the UK’s designated National Measurement Institute for chemical and bioanalytical measurements and an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.”

One of its branches, LGC Standards, is:

“…a leading global producer and distributor of reference materials and proficiency testing schemes. Headquartered in Teddington, Middlesex, UK, LGC Standards has a network of dedicated sales offices extending across 20 countries in 5 continents and more than 30 years experience in the distribution of reference materials.

These high-quality products and services are essential for accurate analytical measurement and quality control, ensuring sound decisions are made based on reliable data. We have an unparalleled breadth of ISO Guide 34 accredited reference material production in facilities at 4 sites across the UK, the US, and Germany.”

LGC Standards entered into a partnership with ATCC, of which the latter is:

“…the premier global biological materials resource and standards organization whose mission focuses on the acquisition, authentication, production, preservation, development, and distribution of standard reference microorganisms, cell lines, and other materials. 

While maintaining traditional collection materials, ATCC develops high-quality products, standards, and services to support scientific research and breakthroughs that improve the health of global populations.”

The "ATCC-LGC Partnership" is designed to facilitate:

“…the distribution of ATCC cultures and bioproducts to life science researchers throughout Europe, Africa, and India and […] to make access to the important resources of ATCC more easily accessible to the European, African, and Indian scientific communities through local stock holding of more than 5,000 individual culture items supported by our local office network delivering the highest levels of customer service and technical support.”

And who owns the patent on the virus? The Rockefeller Foundation!

No comments:

Post a Comment